These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy. Wu SG, Sun JY, Zhou J, Li FY, Zhou H, Lin Q, Lin HX, Bao Y, He ZY. Radiat Oncol; 2014 Dec 16; 9():284. PubMed ID: 25511525 [Abstract] [Full Text] [Related]
8. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy. Truong PT, Olivotto IA, Kader HA, Panades M, Speers CH, Berthelet E. Int J Radiat Oncol Biol Phys; 2005 Apr 01; 61(5):1337-47. PubMed ID: 15817335 [Abstract] [Full Text] [Related]
9. The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy Radiation. Yang TJ, Morrow M, Modi S, Zhang Z, Krause K, Siu C, McCormick B, Powell SN, Ho AY. Ann Surg Oncol; 2015 Dec 01; 22 Suppl 3(Suppl 3):S495-501. PubMed ID: 26130454 [Abstract] [Full Text] [Related]
12. Post-mastectomy Radiation Therapy in Breast Cancer Patients with Nodal Micrometastases. Wu SP, Tam M, Shaikh F, Lee A, Chun J, Schnabel F, Guth A, Adams S, Schreiber D, Oh C, Gerber NK. Ann Surg Oncol; 2018 Sep 01; 25(9):2620-2631. PubMed ID: 29987606 [Abstract] [Full Text] [Related]
14. Heterogeneity in Outcomes of Pathologic T1-2N1 Breast Cancer After Mastectomy: Looking Beyond Locoregional Failure Rates. Bazan JG, Majithia L, Quick AM, Wobb JL, Terando AM, Agnese DM, Farrar W, White JR. Ann Surg Oncol; 2018 Aug 01; 25(8):2288-2295. PubMed ID: 29916008 [Abstract] [Full Text] [Related]
15. Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes. Huo D, Hou N, Jaskowiak N, Winchester DJ, Winchester DP, Yao K. Ann Surg Oncol; 2015 Dec 01; 22(13):4295-304. PubMed ID: 25820998 [Abstract] [Full Text] [Related]
16. Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence? Mamtani A, Patil S, Stempel MM, Morrow M. Cancer; 2017 Jul 15; 123(14):2626-2633. PubMed ID: 28334423 [Abstract] [Full Text] [Related]
19. Outcome of postmastectomy radiotherapy after primary systemic treatment in patients with clinical T1-2N1 breast cancer. Cao L, Ou D, Shen KW, Cai G, Cai R, Xu F, Zhao SG, Xu C, Grellier Adedjouma N, Kirova YM, Chen JY. Cancer Radiother; 2018 Feb 15; 22(1):38-44. PubMed ID: 29306555 [Abstract] [Full Text] [Related]